Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3
The experimentally established mechanism targets of Epinephrine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 8/20 | 0.67 |
| ▸ | ADRA2A known ✓ | P08913 | 6/20 | 0.67 |
| ▸ | ADRB1 known ✓ | P08588 | 6/20 | 0.67 |
| ▸ | ADRB3 known ✓ | P13945 | 5/20 | 0.67 |
| ▸ | ADRA1D known ✓ | P25100 | 5/20 | 0.67 |
| ▸ | ADRA2B known ✓ | P18089 | 4/20 | 0.67 |
| ▸ | ADRA2C known ✓ | P18825 | 4/20 | 0.67 |
| ▸ | ADRA1A known ✓ | P35348 | 4/20 | 0.67 |
| ▸ | ADRA1B known ✓ | P35368 | 4/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 10/20 | 0.67 |
| ▸ | MAPT | P10636 | 10/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.67 |
| ▸ | RECQL | P46063 | 6/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.67 |
| ▸ | DRD2 | P14416 | 5/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.67 |
| ▸ | DRD3 | P35462 | 5/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epinephrine SCHEMBL11236183 | 0.96 | MAPT (0.72) | TDP1MAPTKDM4EADRB2RECQL | |
| Racepinephrine SCHEMBL11236186 | 0.96 | MAPT (0.72) | TDP1MAPTKDM4EADRB2RECQL | |
| Epinephrine SCHEMBL2963939 | 0.96 | MAPT (0.72) | TDP1MAPTKDM4EADRB2RECQL | |
| Racepinephrine SCHEMBL27540379 | 0.96 | MAPT (0.72) | TDP1MAPTKDM4EADRB2RECQL | |
| Epinephrine SCHEMBL1819597 | 0.89 | TDP1 (0.84) | TDP1MAPTKDM4EADRB2RECQL | |
| Norepinephrine SCHEMBL632724 | 0.89 | MAPT (0.74) | TDP1MAPTKDM4EADRB2RECQL | |
| Levodopa SCHEMBL5084107 | 0.88 | KDM4E (0.57) | TDP1MAPTKDM4EADRB2RECQL | |
| Levodopa SCHEMBL5905696 | 0.88 | KDM4E (0.57) | TDP1MAPTKDM4EADRB2RECQL | |
| Isoproterenol SCHEMBL28086470 | 0.88 | MAPT (0.68) | TDP1MAPTKDM4EADRB2RECQL | |
| Levodopa SCHEMBL4412421 | 0.85 | KDM4E (0.53) | TDP1MAPTKDM4EADRB2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0735888-A4 | PURINE COMPOSITIONS AND METHODS FOR ADMINISTRATION | FUKUNAGA ATSUO F (US) | 1999-05-12 | — | — | EP | disclosed |
| EP-0735888-A1 | PURINE COMPOSITIONS AND METHODS FOR ADMINISTRATION | FUKUNAGA, Atsuo F. (US) | 1996-10-09 | — | — | EP | disclosed |
| WO-1995014478-A1 | PURINE COMPOSITIONS AND METHODS FOR ADMINISTRATION | FUKUNAGA ATSUO F (US) | 1995-06-01 | — | — | WO | disclosed |